Yurak ishemik kasalligi vametabolik sindrom ko`p jihatdan bir-biri bilan bog`liqdir.Shuning uchun zamonaviy tibbiyotning dolzarb muammolaridan biri hisoblanadi. O`z vaqtida tashxiz qo`yish va davolash nogironlik va o`limni kamayishiga olib kelisi mumkin. Ularning hayot davomiyligi uzaytirib va ish qobiliyatini saqlaydi.
Maqolada semizlik, arterial gipertenziya (AG), giperlipidemiya, glyukozaga bo`lgan tolerantlik va yurak-qon tomir kasalliklari o'rtasida bog`liqlik mavjudligiga qaratilgan bir qator keng miqyosli tadqiqotlar ma'lumotlari keltirilgan.
Yurak ishemik kasalligi vametabolik sindrom ko`p jihatdan bir-biri bilan bog`liqdir.Shuning uchun zamonaviy tibbiyotning dolzarb muammolaridan biri hisoblanadi. O`z vaqtida tashxiz qo`yish va davolash nogironlik va o`limni kamayishiga olib kelisi mumkin. Ularning hayot davomiyligi uzaytirib va ish qobiliyatini saqlaydi.
Maqolada semizlik, arterial gipertenziya (AG), giperlipidemiya, glyukozaga bo`lgan tolerantlik va yurak-qon tomir kasalliklari o'rtasida bog`liqlik mavjudligiga qaratilgan bir qator keng miqyosli tadqiqotlar ma'lumotlari keltirilgan.
Ишемическая болезнь сердца и метаболический синдром во многом взаимообусловлены. В связи с этим является актуальной проблемой современной медицины, так как своевременная диагностика и лечение этого сочетания может снизить инвалидизацию и смертность у данного контингента больных, продлив их жизнь и сохранив работоспособность.
В статье приведены данные нескольких крупно масштабных исследований, которые были направлены на наличие тесных взаимосвязей между ожирением, артериальной гипертензией (АГ), гиперлипидемией, нарушениями толерантности к глюкозе и ишемической болезнью сердца.
Coronary heart disease and metabolic syndrome are largely interdependent. In this regard, it is an urgent problem of modern medicine, since timely diagnosis and treatment of this combination can reduce disability and mortality in this patients group, prolonging their life and preserving performance. The article presents data from several large-scale studies that were aimed at the presence of close relationships between obesity, arterial hypertension (AH), hyperlipidemia, impaired glucose tolerance and coronary heart disease
| № | Muallifning F.I.Sh. | Lavozimi | Tashkilot nomi |
|---|---|---|---|
| 1 | DJUMAYEV K.S. | ||
| 2 | RAJABOVA G.H. | ||
| 3 | JALILOVA U.D. |
| № | Havola nomi |
|---|---|
| 1 | 1. Breen, D. M. Effects of insulin on the vasculature /D. M. Breen, А. Giacca// Curr Vasc Pharmacol.- 2014.- Vol. 9.- Р. 321–332. 85.Brooks, M. M. Clinical and angiographic risk stratification and differential impact on treatment outcomes in the bypass angioplasty revascularization investigation 2 diabetes (bari 2d) trial / M. M. Brooks [et al.]// Circulation.-2014.- Vol. 126, № 17.- P. 2115-2124. |
| 2 | 2. Bin, H. Impact of metabolic syndrome on clinical outcomes after drug-eluting stent implantation in patients with coronary artery disease / H. Bin [et al.]// Angiology.- 2014.- Vol. 62.- P. 440-446. |
| 3 | 3. Bertoluci, M. C. Diabetes and cardiovascular disease: from evidence to clin-ical practice — position statement 2014 of brazilian diabetes society / M. C. Bertoluci [et al.]// Diabetology and Metabolic Syndrome.- 2014.- Vol. 6, № 1.- P. 58. |
| 4 | 4. Barsukov, A. V. Left ventricular hypertrophy as a marker of adverse cardio-vascular risk in persons of different age groups/ A. V. Barsukov [et al.]// Advances in Gerontology.- 2015.- Vol. 5, № 2.- P. 99-106. |
| 5 | 5. Andrikopoulos, G. Short-term outcome and attainment of secondary preven-tion goals in patients with acute coronary syndrome-results from the coun-trywide target study / G. Andrikopoulos [et al.]// International Journal of Cardiology.- 2013.- Vol. 168, № 2.- P. 922-927 |
| 6 | 6. Andreeva-Gateva, P. A. Cluster analysis of the components of the metabolic syndrome in subjects with an increased risk for diabetes mellitus type 2 / P. A. Andreeva-Gateva [et al.]// Endokrinologya.- 2014.- Vol. 19, № 3.- P. 168-185. |
| 7 | 7. Sostoyanie uglevodnogo obmena pri metabolicheskom sindrome [The state of carbohydrate metabolism in metabolic syndrome] / Kova-lev A.P. [i dr.]// V sbornike: Teoreticheskie i prikladnye problemy sovremennoj nauki i obrazovaniya Materialy Mezhdunarodnoj nauchno-prakticheskoj konferencii.- 2015.- S. 86-91. |
| 8 | 8. Diagnosticheskaya ocenka funkcional'noj aktivnosti sosudistogo endoteliya pri metabolicheskom sindrome i ishemicheskoj bolezni serdca [Diagnostic assessment of the functional activity of the vascular endothelium in the metabolic syndrome and coronary heart disease ] /V. A. Nevzorova [i dr.] //Kardiovaskulyarnaya terapiya i profilaktika.-2011.- T. 10. № 2.- S. 81-87. |
| 9 | 9. Doncov, A. V. Markery subklinicheskogo vospaleniya pri metabolicheskom sindrome i ishe-micheskoj bolezni serdca [Markers of subclinical inflammation in the metabolic syndrome and coronary heart disease]/ A. V. Doncov//Nauchnye vedomosti Belgorodskogo gosudarstvennogo universiteta. Seriya: Medicina. Farmaciya.- 2014.- T. 25. № 4.- S. 62-64 |
| 10 | 10. Nazarova S.O., Shamansurov Sh.Sh. Klinicheskie osobennosti i molekulyarno-geneticheskie mekhanizmy razvitiya cerebral'nyh insul'tov u detej, [linical features and molecular genetic mechanisms of cerebral development stroke in children] Journal of Biomedicine and Practice 2019, vol. 2, issue 4, pp. 116-128 http://dx.doi.org/10.26739/2181-9300-2019-4-13 |
| 11 | 11. Insulinorezistentnost' i endotelial'naya disfunkciya pri metabolicheskom sindrome [Insulin resistance and endothelial dysfunction in metabolic syndrome]/A. A. Kurshakov [i dr.]// Kazanskij medicinskij zhurnal.- 2015.- T. 92. № 2.- S. 173-176. |
| 12 | 12. Prognozirovanie riska restenoza koronarnyh arterij posle ih sten-tirovaniya u pacientov s ozhireniem [Prediction of the risk of coronary artery restenosis after stenting in obese patients] / N.G. Veselovskaya [i dr.]// Serd-ce. Zhurnal dlya praktikuyushchih vrachej.- 2013.- №5.- S. 305-310. |
| 13 | 13. Shishkin, A. N. Vliyanie metabolicheskogo sindroma na techenie ishe-micheskoj bolezni serdca [Effect of metabolic syndrome on the course of coronary heart disease] /A. N. Shishkin, A. S. Droganova//Vestnik Sankt-Peterburgskogo universiteta. Seriya 11. Medicina.- 2014.- Vyp.4. S. 19-25. |
| 14 | 14. Reshyonnye i diskussionnye voprosy patogeneza porazheniya organov-mishenej pri metabolicheskom syndrome [Resolved and debatable issues of the pathogenesis of target organ damage in the metabolic syndrome ] / A. V. Barsukov [i dr.]//Vestnik Severo-Zapadnogo gosudarstvennogo medicinskogo universiteta im. I.I. Mechnikova.- 2014.- T. 3. № 4.- S. 141-146. |
| 15 | 15. Tanatarova G.N. Biokhimicheskie prediktory khronicheskoi serdechnoi nedostatochnosti [Biochemical predictors of chronic heart failure]// Sbor.material.kongressa«Chelovek i lekarstvo». Tezisy dokladov. – 2018. – S.270; |
| 16 | 16 T. Ivashkin, O. M. Drapkina, O. N. Korneeva.– M.: OOO”Izdatel'stvo “Medicinskoe informacionnoe agenstvo”, 2014. — 220 s. |
| 17 | 17. Volkov V. S. Essencial'naya arterial'naya gipertoniya i arterial'naya gipertoniya pri metabolicheskom syndrome [Essential arterial hypertension and arterial hypertension with metabolic syndrome] / V. S. Volkov, O. B. Pose-lyugina//Klinicheskaya medicina.- 2015.- T. 89. № 2.- S. 64-65 |
| 18 | 18. .Rekomendacii po revaskulyarizacii miokarda. Rabochaya gruppa Evro-pejskogo obshchestva kardiologov (ESC) i Evropejskoj associacii kar-diotorakal'nyh hirurgov (EACTS). Razrabotany pri uchastii Evropejskoj associacii po chreskozhnym serdechno-sosudistym vmeshatel'-stvam (EAPCI). [Recommendations for myocardial revascularization. Working group of the European Society of Cardiology (ESC) and the European Association of Cardiothoracic Surgeons (EACTS). Developed with the participation of the European Association for Percutaneous Cardiovascular Interventions (EAPCI). ] Racional'naya Farmakoterapiya v Kardiologii. Prilozhenie k №3.- 2011. |
| 19 | 20. Doskina, E. V. Gipoglikemiya — prediktor serdechno-sosudistyh kata-strof [Hypoglycemia - a predictor of cardiovascular catastrophes] / E. V. Doskina, B. M. Tanhilevich//CardioSomatika.- 2015.-Vyp. 2.- S. 67-71. |
| 20 | 21. Uroven' glikemii kak marker prognoza u bol'nyh infarktom miokar-da s pod"emom segmenta ST [Glycemia level as a prognosis marker in patients with myocardial infarction with ST segment elevation]/ V. N. Karetnikova [i dr.]// Kardiologiya.-2016.- T. 52. № 1.- S. 26-31. |
| 21 | 22. Andreev, V. V. Harakter ateroskleroticheskogo porazheniya aorto-arterial'nogo rusla pri metabolicheskom syndrome [Character of atherosclerotic lesions of the aorto-arterial bed in metabolic syndrome] / V. V. Andreev// Profilakticheskaya i klinicheskaya medicina.- 2015.- Vyp. 3.- S. 64-65. |
| 22 | 23. Bokarev, I. N. O metabolicheskom sindrome [About metabolic syndrome] / I. N. Bokarev// Kliniche-skij opyt Dvadcatki.- 2013.-Vyp. 4.- S. 6-12. |
| 23 | 24. Byl'eva, A. A. Osobennosti techeniya ostrogo koronarnogo sindroma u pacientov s metabolicheskim sindromom [Features of the course of acute coronary syndrome in patients with metabolic syndrome: abstract.]: avtoref. dis. kand. med. nauk: 6.01.05/ A. A. Byl'eva; GBOU VPO MGMSU imeni A.I. Evdokimova Minzdravsocrazvitiya Rossii.-M., 2014.- 15 s. |
| 24 | 25. Dzhanashiia P.Kh., Vladytskaia O.V., Antelava N.A., Berberashvili T.M.,Sukoian G.V. Vzaimosviaz mezhdu narusheniiami v sisteme antioksidantnoi zashchity i razvitiem endotelialnoi disfunktsii pri serdechnoi nedostatochnosti [The relationship between disorders in the antioxidant defense system and the development of endothelial dysfunction in heart failure]// Sbor.material.kongressa «Chelovek i lekarstvo». Tezisy dokladov. – 2018. – S.118; |
| 25 | 23 Grigoryan, O. A. Menopauzal'nyj sindrom u zhenshchin s narusheniyami uglevodnogo obmena: nauch.- prakich. ruk-vo. (2-e izd., dop.) [Menopausal syndrome in women with impaired carbohydrate metabolism] / O. A. Gri-goryan., E. N. Andreeva, I. I. Dedov.- M., 2014.- 75 s. |
| 26 | 24 Evtereva, E. D. Kardiorenal'nye vzaimootnosheniya i kachestvo zhizni u bol'nyh s hronicheskoj serdechnoj nedostatochnost'yu i metaboliche-skim sindromom [Cardiorenal relationships and quality of life in patients with chronic heart failure and metabolic syndrome]: avtoref. dis. kand. med. nauk: 14.01.04/ E. D. Evteeva; GBOU VPO «Volgogradskij gosudarstvennyj medicinskij universi-tet».- Volgograd., 2014 13 s. |
| 27 | 25 Keren, M. A. Sovremennoe sostoyanie i perspektivy razvitiya koronar-noj revaskulyarizacii u bol'nyh saharnym diabetom [The current state and prospects for the development of coronary revascularization in patients with diabetes mellitus]/ M. A. Keren, R. R. Yarbekov// Byulleten' NCSSH im. A.N. Bakuleva RAMN Serdechno-sosudistye zabolevaniya.- 2015.- T. |
| 28 | 26 Panferov A.S., Voronkina A.V,, Avdeeva T.I., Napalkov D.A., Sulimov V.A. K voprosu i rasprostranennosti anemiei sredi patsientov s khronicheskoi serdechnoi nedostatochnostiu [To the issue and prevalence of anemia among patients with chronic heart failure]// Sbor.material.kongressa «Chelovek i lekarstvo». Tezisy dokladov. –2018. – S.259; |
| 29 | 27 .Prognozirovanie serdechno-sosudistyh oslozhnenij, voznikayushchih pri hirurgicheskoj revaskulyarizacii miokarda u lic s ostrymi koronar-nymi sindromami [Prediction of cardiovascular complications arising from surgical myocardial revascularization in individuals with acute coronary syndromes] / N. A. Shibeko [i dr.]// Kardiologiya v Belarusi.-2015.- Vyp. 1.- S. 4-13 |
| 30 | 28 Dzhumaev K.Sh., Razhabova G.H., Oltiboev R.O., Sovremennye aspekty klinicheskoe techenie hronicheskogo serdechnogo nedostatochnosti i problemy skriningovaya diagnostika [Sovreclinical aspects of chronic heart failure are insufficient Tests and Issues Screening Diagnostics] Journal of Biomedicine and Practice 2019, vol. 2, issue 2, pp. http://dx.doi.org/10.26739/2181-9297-2019-2-5 |
| 31 | 29 Chazova I.E., Mychka V.B. Metabolicheskii sindrom. [Metabolic syndrome]–M.: Media Medika. – 2014. – S.161-165 |
| 32 | 30 Shulutko B.I., Makarenko S.V. Standarty diagnostiki i lecheniia vnutrennikh boleznei.[Standards for the diagnosis and treatment of internal diseases]– «ELBI-SPB»Sankt-Peterburg. – 2017. – S.119-122; |